10X Genomics Inc (TXG) stock news · rev $642.8M
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
This TXG news page leads with what 10X Genomics Inc filed — not a scraped headline mill.
No cached 8-K sentence for TXG yet. We will not pad this page with generic market recap.
Latest reported TXG revenue for 2025-12-31 was $642.8M. Net income was -$43.5M. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. TXG currently screens at market cap $4.08B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TXG stock page; for the tape open the quote page.
TXG stock news FAQ
What are TXG's latest revenue and net income?
Latest cached 10X Genomics Inc (TXG) revenue for Dec 31, 2025 was $642.8M. Net income was -$43.5M. Statements: https://lician.com/financials/txg
How did TXG revenue change from the prior cached period?
Cached 10X Genomics Inc (TXG) revenue was up 5.2% from $610.8M (Dec 31, 2024) to $642.8M (Dec 31, 2025). Statements: https://lician.com/financials/txg
What is TXG's market cap?
10X Genomics Inc (TXG) market cap is $4.08B on the latest cached fundamentals snapshot.
What kind of company is TXG?
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Where is TXG stock news listed?
Cached stock news for 10X Genomics Inc (TXG) is listed at https://lician.com/news/txg. Filings: https://lician.com/sec/txg
Not investment advice.